Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Gibson highlighted, "Recursion has a tremendous amount of potential catalysts coming in the next 18 months," referencing the pipeline, partnerships, and platform advancements. He reported, "a pro ...

On Wednesday, major U.S. indices closed mixed, with the Nasdaq rising 1.1% to 23,043.38 and the S&P 500 slipping nearly 0.6% to 6,753.72. The Dow Jones Industrial Average was unchanged at 46,601.78.

Recursion Pharmaceuticals (RXRX) is up 17.9%, or 93c to $6.17. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you ...

New survey data finds that nearly 1 in 5 high schoolers say they or someone they know has had a romantic relationship with artificial intelligence. And 42% of students surveyed say they or someone ...

A lawsuit claiming the Catholic diocese in New Hampshire was negligent in its failure to protect kids from sexual abuse in the 1970s cannot proceed to trial, the state’s highest court ruled Wednesday, ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...

Rabbi Danny Schiff had a rule: no national letters. The community scholar of the Jewish Federation of Greater Pittsburgh avoided open statements about far-off politics. But this month, he broke that ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...